A major breakthrough in cancer study is emerging with the use of mini-antibodies to re-engage mutated p53. This vital malignant inhibitor protein is frequently inactivated in many types of malignancies, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research